Kojiro Tashiro

792 total citations
56 papers, 316 citations indexed

About

Kojiro Tashiro is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Kojiro Tashiro has authored 56 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Pulmonary and Respiratory Medicine, 19 papers in Surgery and 9 papers in Oncology. Recurrent topics in Kojiro Tashiro's work include Prostate Cancer Treatment and Research (33 papers), Prostate Cancer Diagnosis and Treatment (23 papers) and Bladder and Urothelial Cancer Treatments (12 papers). Kojiro Tashiro is often cited by papers focused on Prostate Cancer Treatment and Research (33 papers), Prostate Cancer Diagnosis and Treatment (23 papers) and Bladder and Urothelial Cancer Treatments (12 papers). Kojiro Tashiro collaborates with scholars based in Japan, Hong Kong and China. Kojiro Tashiro's co-authors include Yukihiko Oishi, Takashi Hatano, Akira Furuta, Takahiro Kimura, Fumihiko Urabe, Shin Egawa, Kosuke Iwatani, Shoji Kimura, Shun Sato and Manabu Aoki and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and British Journal of Urology.

In The Last Decade

Kojiro Tashiro

44 papers receiving 300 citations

Peers

Countries citing papers authored by Kojiro Tashiro

Since Specialization

Citations

This map shows the geographic impact of Kojiro Tashiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kojiro Tashiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kojiro Tashiro more than expected).

Fields of papers citing papers by Kojiro Tashiro

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kojiro Tashiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kojiro Tashiro. The network helps show where Kojiro Tashiro may publish in the future.

Co-authorship network of co-authors of Kojiro Tashiro

This figure shows the co-authorship network connecting the top 25 collaborators of Kojiro Tashiro. A scholar is included among the top collaborators of Kojiro Tashiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kojiro Tashiro. Kojiro Tashiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluating CRPC Definition: Comparing Upfront ARSI and Conventional Hormonal Therapy for Metastatic Hormone Sensitive Prostate Cancer (mHSPC) in Real World Propensity Score Matched Cohort 2025 ·The Prostate ·(unknown), Fumihiko Urabe, (unknown), Takafumi Yanagisawa, Wataru Fukuokaya, Keiichiro Mori, Kojiro Tashiro, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Shunsuke Tsuzuki, Hiroki Yamada, Jun Miki, (unknown), (unknown)	1
2	Locations of metastases in and oncological outcomes of patients with metastatic castration-sensitive prostate cancer: Real-world data from a multicenter study 2025 ·Urologic Oncology Seminars and Original Investigations ·Fumihiko Urabe, Kojiro Tashiro, (unknown), Takafumi Yanagisawa, (unknown), (unknown), (unknown), Wataru Fukuokaya, (unknown), Kosuke Iwatani, (unknown), (unknown), (unknown), Shoji Kimura, (unknown), Shunsuke Tsuzuki, Takaya Sasaki, (unknown), (unknown), Takahiro Kimura	1
3	Comparison of abiraterone, enzalutamide, and apalutamide for metastatic hormone‐sensitive prostate cancer: A multicenter study 2024 ·The Prostate ·Takafumi Yanagisawa, Wataru Fukuokaya, Shingo Hatakeyama, Shintaro Narita, (unknown), (unknown), (unknown), Fumihiko Urabe, (unknown), Kojiro Tashiro, Kosuke Iwatani, (unknown), Tomonori Habuchi, Takahiro Kimura	4
4	Changes in the treatment landscape of metastatic hormone‐sensitive prostate cancer following approval of upfront androgen receptor signaling inhibitors: A multicenter study 2024 ·International Journal of Urology ·Fumihiko Urabe, (unknown), Takafumi Yanagisawa, Wataru Fukuokaya, Keiichiro Mori, Kojiro Tashiro, (unknown), (unknown), (unknown), (unknown), (unknown), Kosuke Iwatani, (unknown), (unknown), (unknown), Shunsuke Tsuzuki, Tatsuya Shimomura, Hiroki Yamada, Jun Miki, Takahiro Kimura, (unknown)	3
5	Site-Specific Differences of Eligibility for Adjuvant Immunotherapy Among Urothelial Carcinoma Patients Treated With Radical Surgery: Results From a Multicenter Cohort Study 2024 ·Clinical Genitourinary Cancer ·(unknown), Fumihiko Urabe, Wataru Fukuokaya, Kosuke Iwatani, (unknown), (unknown), Keiichiro Mori, (unknown), Takafumi Yanagisawa, Shoji Kimura, Kojiro Tashiro, Shunsuke Tsuzuki, Yuta Yamada, (unknown), Jeremy Yuen‐Chun Teoh, Tatsuya Shimomura, Hiroki Yamada, Akira Furuta, Jun Miki, Takahiro Kimura	0
6	Validation study on the 2 mm diameter cutoff in lymph node‐positive cases following radical prostatectomy in accordance with the AJCC/UICC TNM 8th edition: Real‐world data analysis from a Japanese cohort 2024 ·International Journal of Urology ·Masashi Kato, Masaki Shiota, Takahiro Kimura, (unknown), Akihiro Hirakawa, (unknown), Kojiro Tashiro, Yoshiyuki Matsui, Katsuyoshi Hashine, Ryoichi Saito, Akira Yokomizo, Yoshiyuki Yamamoto, Shintaro Narita, Kohei Hashimoto, Hiroaki Matsumoto, Shusuke Akamatsu, Naotaka Nishiyama, Masatoshi Eto, Hiroshi Kitamura, Toyonori Tsuzuki, (unknown)	0
7	Optimizing prostate cancer detection in transition zone: an analysis of apparent diffusion coefficient values in prostate magnetic resonance imaging evaluation with Prostate Imaging Reporting and Data System (PI-RADS) assessment 2024 ·Translational Andrology and Urology ·(unknown), Fumihiko Urabe, (unknown), (unknown), Kosuke Iwatani, (unknown), Kojiro Tashiro, Manabu Aoki, Shun Sato, Hiroyuki Takahashi, Shunsuke Tsuzuki, Kenta Miki, Takahiro Kimura	1
8	Clinical significance of PSA dynamics in castration-sensitive prostate cancer treated with ARSI doublet therapy: A multicenter study 2024 ·Urologic Oncology Seminars and Original Investigations ·Fumihiko Urabe, Shingo Hatakeyama, Takafumi Yanagisawa, (unknown), (unknown), (unknown), (unknown), Wataru Fukuokaya, Keiichiro Mori, Kojiro Tashiro, Kosuke Iwatani, Tatsuya Shimomura, (unknown), Tomonori Habuchi, Takahiro Kimura	2
9	The clinical impact of ureteroscopy for upper tract urothelial carcinoma: A multicenter study 2023 ·International Journal of Urology ·(unknown), Fumihiko Urabe, (unknown), (unknown), Hirotaka Suzuki, (unknown), (unknown), Wataru Fukuokaya, Kazuhiro Takahashi, Kosuke Iwatani, (unknown), (unknown), (unknown), Takafumi Yanagisawa, Kojiro Tashiro, Steffi Kar Kei Yuen, Shun Sato, Shunsuke Tsuzuki, Jun Miki, Takahiro Kimura, (unknown)	0
10	Prognostic significance of subclassifying pathological T3 upper tract urothelial carcinoma: Results from a multicenter cohort study 2023 ·International Journal of Urology ·(unknown), Fumihiko Urabe, (unknown), (unknown), Wataru Fukuokaya, Kosuke Iwatani, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Keiichiro Mori, Shoji Kimura, Kojiro Tashiro, Shunsuke Tsuzuki, Jun Miki, Shun Sato, Hiroyuki Takahashi, Takahiro Kimura, (unknown)	4
11	Effect of Adequate Local Radiation Dose on Oncological Outcomes in Localized Prostate Cancer Patients Treated With Low-dose-rate Brachytherapy 2023 ·Anticancer Research ·(unknown), Fumihiko Urabe, Kenta Miki, Hirotaka Suzuki, Kosuke Iwatani, Kojiro Tashiro, Shunsuke Tsuzuki, Akira Furuta, Takaya Sasaki, Shun Sato, Hiroyuki Takahashi, Manabu Aoki, (unknown)	1
12	Patients with PSA below 0.2 ng/mL at 8 years post high‐dose‐rate brachytherapy have an extremely low risk of subsequent recurrence 2023 ·International Journal of Urology ·(unknown), Fumihiko Urabe, Kosuke Iwatani, (unknown), Kojiro Tashiro, Mariko Honda, Yusuke Koike, Tatsuya Shimomura, Shun Sato, Hiroyuki Takahashi, Kenta Miki, Manabu Aoki, Takahiro Kimura	0
13	Characteristics of mild and severe apalutamide‐related cutaneous adverse events in patients with prostate cancer: A review of the literature 2023 ·The Journal of Dermatology ·(unknown), Yoshimasa Nobeyama, (unknown), Kojiro Tashiro, Takahiro Kimura, Akihiko Asahina	8
14	Treatment Results of High-dose-rate Brachytherapy and External Beam Radiation With Long-term Androgen Deprivation Therapy for Patients With Metastatic Prostate Cancer 2023 ·Anticancer Research ·Hirotaka Suzuki, Fumihiko Urabe, Kosuke Iwatani, (unknown), (unknown), Kojiro Tashiro, Shunsuke Tsuzuki, Mariko Honda, Yusuke Koike, Manabu Aoki, Shun Sato, Hiroyuki Takahashi, Kenta Miki, (unknown)	0
15	Predictive factors for disease progression after salvage radiation therapy in biochemical recurrent patients treated by radical prostatectomy 2023 ·Prostate International ·(unknown), Shoji Kimura, Fumihiko Urabe, Kosuke Iwatani, Kojiro Tashiro, A. Ochi, Hirokazu Abe, Manabu Aoki, Takahiro Kimura	3
16	The prognostic significance of the clinical T stage and Grade Group in patients with locally advanced prostate cancer treated via high-dose-rate brachytherapy and external beam radiation 2023 ·International Journal of Clinical Oncology ·(unknown), Fumihiko Urabe, Kosuke Iwatani, (unknown), (unknown), Kojiro Tashiro, Shunsuke Tsuzuki, Mariko Honda, Yusuke Koike, Tatsuya Shimomura, Manabu Aoki, Shun Sato, Hiroyuki Takahashi, Kenta Miki, Takahiro Kimura	4
17	Knotted ureteral single‐J stent in a patient with ureterocutaneostomy 2021 ·IJU Case Reports ·(unknown), Fumihiko Urabe, Kosuke Iwatani, (unknown), Masatoshi Tanaka, Kojiro Tashiro, Takahiro Kimura, Shunsuke Tsuzuki, Shin Egawa	1
18	Phase II study of the efficacy of abirateron acetate with dutasteride for castration-resistant prostate cancer. 2021 ·Journal of Clinical Oncology ·Hideyasu Matsuyama, Masaki Shiota, Kojiro Tashiro, (unknown), Shizuyo Horiyama, Masatoshi Eto, Shin Egawa, Jun Haginaka, Ryo Inoue	1
19	Blood platelet volume predicts treatment-specific outcomes of metastatic castration-resistant prostate cancer 2020 ·International Journal of Clinical Oncology ·Wataru Fukuokaya, Takahiro Kimura, Fumihiko Urabe, Shoji Kimura, Kojiro Tashiro, Shunsuke Tsuzuki, Yusuke Koike, Hiroshi Sasaki, Kenta Miki, Shin Egawa	2
20	Vertebral angiography of cerebellar astrocytoma. Tumor stain, tumor circulation, CT and angiography in diagnosis 1982 ·Kenichi Kitaoka, Tetsuhide Ito, Kojiro Tashiro, Hiroshi Abe, (unknown), Kazuo Miyasaka	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact